Preimplantation Genetic Testing Market - Industry Size, Share, Growth & Forecast 2027 | UnivDatos

 

The global preimplantation genetic testing market is anticipated to witness an uptick owing to favorable government initiatives, increasing public-private investments in the field of preimplantation genetic testing, and the growing concern regarding fertility among people around the world. For instance, in America, 1 out of 8 couples encounters fertility hurdles and nearly 12% of women experience difficulties becoming pregnant or carrying a child to term. Moreover, as per the US government fertility statistics, in 2019, there were 58.2 births year per 1,000 women of age between 15 and 44. this was the lowest birth rate in the US in the 33 years as claimed by CDC. This can lower birth rate can also be attributed to the growing tendency among women to conceive later in life and focus more on their careers.
Request Sample Copy of this Report @ https://univdatos.com/get-a-free-sample-form-php/?product_id=18509
According to UnivDatos Market Insights (UMI)’ research report “Global Preimplantation Genetic Testing Analysis, 2020”, the preimplantation genetic testing market is projected to grow at a CAGR of around 10% during 2021-27F. The increase in the number of people opting for IVF procedures and the ongoing trend of replacing traditional genomic technologies with advanced genetic techniques are also some of the factors driving the growth of the preimplantation genetic testing market.

Based on the procedure type, the market is fragmented into preimplantation genetic screening and preimplantation genetic diagnosis. The preimplantation genetic screening segment accounted for a considerable share in 2020 and is anticipated to register a lucrative CAGR during the forecast period owing to the benefits offered by the screening such as an increased likelihood of healthy pregnancy, a better rate of implantation, and reduced cycle time of IVF, etc.

Aneuploidy Centers Segment to Witness Robust growth

Based on application, the market is segmented into aneuploidy, structural chromosomal abnormalities, single-gene disorders, x-linked disorders, HLA typing, and gender identification. The aneuploidy segment had the highest revenue and CAGR growth in the analyzed period owing to the rising incidences of aneuploidy due to the increasing maternal age. However, the HLA Typing segment is expected to grow at the highest CAGR over the projected timeframe.

Request Sample Copy of this Report @ https://univdatos.com/get-a-free-sample-form-php/?product_id=18509

North America to Grab Lion’s Share, and witnessed Explicit Growth

Based on the region, North America dominated the global preimplantation genetic testing market in 2020. The region is projected to maintain its dominance during the forecasted period 2021-27 owing to the presence of well-established healthcare infrastructure and growing adoption of advanced diagnostics in the region. North America is expected to skyrocket with a CAGR of XX% in the forecast period owing, as stated in UnivDatos Market Insights (UMI)’ research report “Global Preimplantation Genetic Testing Analysis, 2020”. 
According to UnivDatos Market Insights (UMI)’, the key players with a considerable market share in the Preimplantation Genetic Testing Market include Thermo Fisher Scientific Inc., Agilent Technologies Inc., PerkinElmer Inc., Illumina, Inc., The Cooper Companies Inc., Bioarray S.L., Natera Inc., Quest Diagnostics Inc., Laboratory Corporation of America Holdings, F. Hoffmann-La Roche AG, among others. The players are focused on launching products for gaining customers' traction and expanding their geographical reach to get a competitive edge in the industry.  

“Global Preimplantation Genetic Testing Market Analysis, 2020” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for preimplantation genetic testing providers across the Globe. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitors’ capabilities on 16 parameters. This will help companies in the formulation of go to Market Strategies and identifying the blue ocean for its offerings.
For More Informative Information, Please Visit Us @ https://univdatos.com/report/preimplantation-genetic-testing-market/

Market Segmentation:

1.      By Product & Services (Reagents & Consumables, Instruments, and Software & Services)

2.      By Technology (Next-Generation Sequencing (Ngs), Polymerase Chain Reaction, Fluorescent In-Situ Hybridization, Comparative Genomic Hybridization, and Single Nucleotide Polymorphism)

3.      By Procedure Type (Preimplantation Genetic Screening and Preimplantation Genetic Diagnosis)

4.      By Applications (Aneuploidy, Structural Chromosomal Abnormalities, Single-Gene Disorders, X-Linked Disorders, HLA Typing, and Gender Identification)

5.      By Region (North America, Europe, Asia-Pacific, Rest of the World)

6.      By Company (Thermo Fisher Scientific Inc., Agilent Technologies Inc., PerkinElmer Inc., Illumina, Inc., The Cooper Companies Inc., Bioarray S.L., Natera Inc., Quest Diagnostics Inc., Laboratory Corporation of America Holdings, F. Hoffmann-La Roche AG, etc.)

Key questions answered in the study:

1.      What are the current and future trends of the preimplantation genetic testing industry?

2.      How the industry has been evolving in terms of product & services, application, technology, and procedure type?

3.      How the competition has been shaping across the countries followed by their comparative factorial indexing?

4.      What are the key growth drivers and challenges for the preimplantation genetic testing industry?

5.      What are the customer orientation, purchase behavior, and expectations from preimplantation genetic testing firms across various regions?

Table of Content –

1 MARKET INTRODUCTION

2 RESEARCH METHODOLOGY OR ASSUMPTION

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 COVID-19 IMPACT

6 GLOBAL PREIMPLANTATION GENETIC TESTING MARKET REVENUE

7 MARKET INSIGHTS BY PRODUCT & SERVICES

8 MARKET INSIGHTS BY TECHNOLOGY

9 MARKET INSIGHTS BY PROCEDURE TYPE

10 MARKET INSIGHTS BY APPLICATION

11 MARKET INSIGHTS BY REGION

12 PREIMPLANTATION GENETIC TESTING MARKET DYNAMICS

13 PREIMPLANTATION GENETIC TESTING MARKET OPPORTUNITIES

14 PREIMPLANTATION GENETIC TESTING MARKET TRENDS & INSIGHTS

15 LEGAL & REGULATORY FRAMEWORK

16 DEMAND AND SUPPLY SIDE ANALYSIS

17 VALUE CHAIN ANALYSIS

18 COMPETITIVE SCENARIO

19 COMPANY PROFILED

20 DISCLAIMER

Browse Other Related Research Reports from UnivDatos Market Insights

·        Defibrillator Market to Reach US$ 15.5 Billion by 2027 Globally |CAGR: 5.3%|

·        3D Printed Drugs Market to Reach US$ 2,064.8 Million by 2027 Globally | CAGR: 15.2% |

·        Gene Therapy Market to Reach US$ 20.9 Billion by 2027, Globally |CAGR: 29.7%|

·        Healthcare Cloud Computing Market to Reach US$ 80.5 Billion by 2027 Globally |CAGR: 14.5%|